Although the precise mechanisms responsible for antibody formation are unknown, it is now generally accepted that most if not all individual plasma cells produce antibodies of a single specificity (1-5) and immunoglobulin molecules of a single allotypic type (6-8). We can therefore ask how antibodyforming cells of different specificities axe arranged and distributed in the lymph nodes and spleen. The answer to this question may provide some insight into the mechanism of antibody production, and it has some relevance to the clonal selection hypothesis of antibody formation (9-11). According to this hypothesis, a very small number of preexisting antibody-bearing cells are present in an animal prior to antigen administration. Contact of these cells with administered antigen would then lead to a rapid proliferation of these cells and thus to the production of a large amount of that antibody initially present on the cell. If such a hypothesis were correct, one might expect to see, especially soon after immunization, groups or clones of plasma cells, each producing antibody of the same specificity, in lymph node sections of animals immunized with two different antigens. Studies of the distribution of ceils producing antibodies of different specificities were first performed by White in a brief study in 1958 (1). He found, by employing immunofluorescent techniques in animals immunized with protein antigens, that cells of different specificities were randomly intermixed. In contrast, in more recent studies by Braun and Nakano (12) and Young and Friedman (13) using the Jerne plaque technique, it was found that antibody-forming cells making antibodies to sheep and chicken red blood cells appeared to be donally distributed in the spleens of mice.
were immunized with two separate antigens, ovalbumin (OVA) and bovine "y-globulin (BGG); here the antigenic determinants are on separate molecules. In other experiments, animals were immunized with dinitrophenylated bovine ~/-globulin, or dinitrophenylated-poly-L-lysine bovine serum albumin complexes (DNP-PLL.BSA); here two antigenic determinants are on the same molecule or immunogenic complex. Antibody-forming cells with different specificities were found both randomly mixed and separately segregated. Which of these distribution patterns was obtained depended upon the method of immunization and the physical state of the antigens employed.
Materials and Methods
Guinea pigs (400-500 g) were obtained from Carom Research Laboratories, Wayne, N. J.; bovine serum albumin (BSA) and ovalbumin (OVA) from General Biochemicals, Chagrin Falls, Ohio; and bovine "/-globulin (BGG) from Armour Pharmaceutical Co., Kankakee, Ill. Guinea pig T2-globulin was purified from a commercially obtained fraction II (Pentex, Inc., Kankakee, Ill.) by passing it through a DEAE-cellulose column equillibrated with a sodium phosphate buffer, .01 • pH 7.6. Poly-TAysine (PLL), molecular weight 115,000 was purchased from Pilot Chemical Co., Watertown, Mass.; Freund's complete adjuvant (CFA) from Dffco Laboratories, Inc., Detroit, Mich.; and pertussis vaccine from Eli Lilly & Co., Indianapolis, Ind. 1-Fluoro-2,4-dinitrobermene (DNFB) was obtained from Eastman Organic Chemicals, Rochester, N. Y. Fluorescein isothiocyanate (FITC) and tetramethyl rhodamine isothiocyanate (RITC) were purchased from Baltimore Biological Laboratories, Baltimore, Md. DNP-PLL, DNP-BGG, and DNP guinea pig T-globulin conjugates were prepared by reacting the PLL or the protein with DNFB under alkaline conditions (14) and the degree of DNP substitution calculated as previously described (15) . The subscript refers to the number of DNP groups per molecule. The following conjugates were prepared: DNPs-BGG, DNPz6BGG, DNP~BGG, DNP25 guinea pig T-globulin, and DNP23PLL. DNP-PLL albumin electrostatic complexes were prepared as previously described (5) . Lymph node and spleen sections were made using the cold alcohol fixation and wax-embedding technique of Guy Sainte-Marie (16) .
Preparation of Fluorescein-and Rkodamine-Labded Antibodies.--Rabbits were immunized
with BSA, OVA, BGG, or DNP6~BGG in complete adjuvant. Anti-BSA, OVA, and BGG antibodies were obtained from the serum as the T-globulin fraction after precipitation two times with 33% NH4SO4. Specific anti-DNP antibodies were isolated by the method of Farah et al. (17) from the serum of rabbits immunized with DNP66 BGG. The anti-BSA and anti-BGG antibodies were conjugated with FITC and purified on Sephadex and DEAE columns according to the technique of McDevitt et al. (18) . The anti-OVA antibodies and the pure anti-DNP antibodies were conjugated with RITC according to the same method except that after Sephadex filtration the conjugate was absorbed with charcoal as described by Nairn
(19).
Immunofluorescer~ Teckn/que.--The sections to be examined were dewaxed in cold xylene, rehydrated in graded alcohols, and finally placed in pH 7.2 phosphate buffer. The anti-BSA, BGG, and OVA-producing cells were detected using the Coon's sandwich technique (20) . BSA, BGG, and OVA at a concentration of 250 #g/ml were used as the middle layer antigens. The slides were then washed and treated with the appropriate fluoresceinated or rhodaminelabeled antibodies. Anti-DNP-producing cells were detected as previously described (4) using DNPz6BGG or DNP25 guinea pig T-globulin as the middle layer detecting antigens. In animals immunized with DNPsBGG, DNP~, guinea pig T-globulin was used as the middle layer antigen. Mter washing, the slides were treated with rhodamlne-labeled anti-DNP antibody.
Controls: Slides were incubated with saline instead of the middle layer antigens, the subsequent steps being identical with those described above. After this procedure, no stained cells were seen except when fluoresceinated anti-BGG antibody was used; here a very rare, and weakly stained green cell was seen in an occasional section.
With these techniques, in animals immunized so as to produce ceils of different specificities, cells of one specificity were stained green and cells of the other specificity were stained orange; if a cell were producing antibodies of two different specificities it would be stained yellow. A detailed discussion of the validity of these methods as well as the problems assedated with them is given in reference 4.
Microscopy: A Leitz Ortholux microscope equipped with an I-Ib 200 ultraviolet light source, a UG-1 exciter filter, and a GG-13 barrier filter was used. Photography was performed with either high speed Ektachrome daylight film or Anscochrome "SO0" daylight film. Exposure times were from 60 to 180 secs.
Immunization (general):
Animals were immunized with the antigens mixed with either an equal volume of complete Freund's adjuvant or an equal volume of pertussis vaccine (20 X 109 or organisms/ml). In all the cases, the final admlni~tered volume of Freund's adjuvantcontaining emulsion or pertussls vaccine antigen mixture was 0.1 ml/site. Animals were immunized with the two separate antigens, OVA and BGG, or with antigens containing two determinants are on the same molecule; either DNP~BGG or DNP-PLL.BSA.
The amount of each antigen given, sites of immunization, and time intervals between immunization and sacrifice are shown in detail in the respective tables and are also discussed below in the section Experimental Design.
Preparation of Heat Denatured
Antigens.--OVA or BGG solutions at a concentration of 10 mg/ml were added dropwise to boiling 0.15 N saline. Boiling was continued for 10 min. The precipitated proteins were then washed by centrifugation three times in 0.15 N saline and the precipitate was diluted to the appropriate concentration.
Antigens Carrying Two Determinants.--Two different antigens were used, each of which carried two determinants on the same molecule or immunogeuic complex. The first was DNPr, BGG. It has been previously demonstrated that when animals are immunized with DNP-BGG conjugates bearing only a few DNP groups, anti-DNP antibodies are produced as well as antibodies to the unmodified BGG carrier, and that these two kinds of antibody are produced in separate cells (4) .
The second type of antigen employed carrying two determinants was DNP23PLL complexed to BSA. The immune response to DNP-PLL is under genetic control. Only 30% of Harfley guinea pigs can make an immune response to DNP-PLL (21) (22) (23) . However, animals genetically unable to respond to DNP-PLL can be made to produce anti-DNP antibodies if the positively charged DNP-PLL is electrostatically complexed to a negatively charged foreign albumin. Thus, in genetic nonresponder animals DNP-PLL behaves as a hapten and the BSA acts as the carrier (24) . After immunization of animals with this complex, anti-DNP antibodies are produced as well as antibodies to the BSA. Again it had been shown that these antibodies are produced in separate ceils (5) . The distribution of these antibody-producing ceils was determined both in genetic nonresponder animals immunized with DNP~3-PLL.BSA (here the presence of the BSA is absolutely essential for the production of anti-DNP antibodies) and also in genetic responder animals immunized with DNP23PLL-BSA.
The number, density, location, and arrangement of antibody-forming cells of each specificity was determined by inspection; in selected cases, counts of ceils of each specificity were performed. The density of antibody-forming cells in the lymph nodes and spleen is described in the tables as low density, moderate density, and high density. These are defined arbitrarily Anlmn]g were bled from the retroorbital plexus on the day of sacrifice and the presence of circulating antibody was determined by gel diffusion using Hyland Immunoplates, Pattern C, Hyland Laboratories, Los Angeles, Calif. Antigens were used at a concentration of 0.25 mg/ml.
Experimental Design
In the animals immunized with the two separate antigens, OVA and BGG, an attempt was made to see ff varying the conditions of immunization would influence the degree of mixing of the cells of separate specificities.
1. The degree of in vitro miTing of the two antigens was varied prior to injection. This experimental design is shown in Table I. 2. The two separate antigens, OVA and BGG, were not mixed in vitro but were injected into separate sites, these sites being either closely or distantly spaced. This experimental design is also shown in Table I. 3. Since admlni~tration of Freund's complete adjuvant produces first a severe degree of hyperplasia and granuloma formation and then extensive fibrosis and distortion of the node architecture, immunization of animals with BGG and OVA in pertnssis vaccine was performed. Here, although hyperplasia and secondary follicle formation are prominent, severe distortion of the node architecture does not take place. Again these two antigens were either mixed and injected into the same sites or were separated and injected into separate sites. This experimental design is .qhown in Table H. 4. Another variation in the method of immunization was to make the antigen insoluble. Here it was found that immunization with heat-denatured OVA and BGG did not lead to a significant degree of antibody production to soluble OVA and BGG, but did result in an immune state in these ~nlmais in which a rapid and vigorous booster response could be elicited by subsequently immunizing these animals with soluble OVA and BGG. The experimental design of these experiments is shown in Tables IV, V, VI, and VII.
In this fourth variation of the method of immunization, the animals were therefore immunized first with the denatured OVA and BGG and then boosted with the soluble OVA and BGG. In order to see ff the sites of injection of the insoluble antigens would influence the number and distribution of each type of antibody-forming cell which resulted from boosting with soluble antigen, the animals were immunized with the insoluble antigens and boosted with the soluble antigens in a variety of combinations:
a. The insoluble antigens were injected separately on opposite sides of the body and the soluble boosting antigens subsequently injected either ipsilaterally, contralaterally, or mixed.
b. The two insoluble antigens, OVA and BGG, were mixed in vitro and injected symmetrically into the four footpads, and the soluble boosting antigens were subsequently injected unilaterally or were mixed and injected symmetrically into the four footpads.
As a control for the above experiment, in which the ability of immunization with insoluble OVA and BGG to prepare the animal for a booster response with soluble OVA and BGG was tested, the following experiment was also performed: Animals were immunized only with Freund's complete adjuvant and saline; the animals were subsequently boosted with soluble OVA and BGG.
In animals injected with antigens containing two determinants on the same molecule, there was no variation in the method of imm~mization. Antigens were always incorporated into CFA, and the fouffoot pads were injected.
RESULTS

General
Observations.--AU the animals responded with the production of antibodies of two specitlcities as determined by fluorescein (green) or rhodamine (orange) labeling of antibody-producing ceils. In no instance were there yellow plasma cells, indicating antibodies of two specificities. However, plasma-contalnlng interstitial areas of the lymph node, as well as the interior of blood vessels, were frequently stained yellow, indicating that sites containing antibodies of both specificities were indeed stained yellow. This is shown in Figs. 1 a and b.
There was a correlation between the sites of antigen injection and the density of antibody-forming cells in the draining lymph nodes. The antibodyforming cell density was highest in the immediate draining lymph nodes and was considerably less in lymph nodes distant from the site of antigen injection. For example, in those animals immunized in the rear footpads and posterior flank, high antibody-formlng cell densities were present in the popliteal, flank, and inguinal nodes; low cell densities were seen in the axillary and scapular nodes. Examples of this observation are seen in Table II .
In the animals immunized with Frennd's adjuvant, the density of antibodyforming cells in lymph node sections was far greater than that seen in animals immunized with the same antigen and pertussis vaccine.
In the lymph nodes, antibody-forming cells were seen within the diffuse cortex between lymphoid follicles and also in the medullary areas of the lymph node. An occasional antibody-forming cell was also seen in the area of closely packed small lymphocytes of the lymphoid nodule. Yellow staining in a dendritic pattern due to adsorbed "y-globulln over germinal center areas was only rarely seen. Why this type of staining was not more commonly seen is not known.
In the spleen, antibody-forming cells were seen in the lymphoid cuffs surrounding the central arteries, and also at the periphery of lymphoid follicles in the red pulp.
Distribution of Antibody-Forming Cells.--In all animals immunized with soluble OVA and BGG, either in CFA or pertussis vaccine, the anti-OVAproducing cells and the anti-BGG-producing cells were always randomly and intimately mixed. This is illustrated in Figs. 2 a-c. As can be seen in Tables I and II, this result was not influenced by the degree of in vitro mixing of the antigens prior to injection or by the sites of antigen injection.
Similar mixing of cells of different specificities was always seen in animals immunized with antigens bearing two determinants, and DNP~BGG or DNP-PLL. BSA gave the same results These are shown ill Table III . Accordingly, an attempt was made to determine the effect of a more insoluble antigen. It was found that animals immunized with heat-denatured OVA and BGG produced no antibodies as detected by gel diffusion and only in an occasional animal were a few weak anfi-BGG-producing cells seen in lymph node sections. In no case were anti-OVA-producing cells found. These results are shown in Table 1V . However, other animals immunized with insoluble OVA and BGG were then boosted with soluble OVA and BGG. This lead to the appearance of a large number of antibody-forming cells in the lymph nodes and spleen and to the presence of detectable anti-BGG and anti-OVA antibodies in the serum of these animals. These results are shown in Tables V and VI. In the first set of these experiments shown in Table V , the animals were immunized first with insoluble OVA in the right half of the body and with insoluble BGG in the left half of the body; these animals were then subsequently boosted with soluble OVA and BGG. The soluble antigens were given either ipsilaterally or contralaterally in respect to the first immunization, or were given mixed together. As can be seen, the ratios of the numbers of BGG to OVA cells in the nodes in the fight and left sides of the body bore no constant relationship to the sites of either the first or second immunization. In general there were more anti-BGG cells than anti-OVA cells. Here, however, for the first time in four of these eight animals, lymph nodes were found in which some areas of the node showes cells of a single specificity grouped together. This is illustrated in Figs. 3 a-b and Figs. 4 a-c. In the spleens of these animals, cells of different specificitied were always randomly mixed.
In the next set of experiments, with insoluble antigens, shown in Table VI , the insoluble OVA and BGG were mixed together and injected symmetrically into the four footpads. The animals were then boosted with soluble OVA and BGG either symmetrically or asymmetrically. Again there was no constant relationship between the ratios of the anti-BGG cells to anti-OVA cells in terms of the sites of either the first or second antigen injections. However, in three of these six animals, lymph nodes were again found which in some areas showed cells of one specificity grouped together. As in the previous experiment, the spleens of these animals showed cells of different specificities to be always To determine the degree of response to soluble antigens alone in animals not previously immunized with insoluble antigens, a group of five animals was injected with only saline in CFA. They were then boosted with soluble OVA and BGG as shown in Table VII . Here, only a few antibody forming cells were seen and no anti-OVA or anti-BGG antibodies were detected in the sera of these animals by gel diffusion. Thus, immunization with these insoluble protein antigens produces an immune response characterized by little or no antibody production but one which prepares the animal for a vigorous booster response to soluble antigens.
DISCUSSION
The observations in the present study are in agreement with the concept that individual antibody-forming cells produce antibodies of a single specificity. In addition, it was found that cells responding to different soluble antigens were always randomly intermixed. These results were obtained whether the animals were immunized with the soluble OVA and BGG mixed together in varying degrees or whether the soluble OVA and BGG were injected separately into closely or distantly separated sites. Identical, random intermixing of cells of different specificities was obtained in animals also immunized with antigens in which the two antigenic determinants were on the same molecule or immunogenic complex. However, when animals were immunized with heat-denatured particulate OVA and BGG and then boosted with soluble OVA and BGG a somewhat dififerent result was obtained. Here, although cells of different specificities were also found to be intermixed in some lymph nodes, other lymph nodes in the same animal often showed areas in which cells of one specificity were grouped together. Of interest was the fact that animals immunized only with heatdenatured OVA and BGG produced very few anti-BGG cells and no anti-OVA cells, yet such animals were prepared for a rapid booster response to soluble OVA and BGG. Gell and Benacerraf (25) had previously observed that, although animals immunized with heat-denatured proteins produced no antibody to the soluble forms of these proteins, they did manifest delayed reactions to the soluble proteins. Steiner and Eisen (26) recently demonstrated that injection of hapten protein conjugates in rabbits, in amounts too small to elicit detectable antibody formation, nevertheless prepared the animal for partial secondary response.
Another observation which was made was that in animals immunized unilaterally with the priming insoluble antigens OVA and BGG, and then boosted with the soluble antigen either ipsilaterally or contralaterally or 
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As above 9 Second immunizing antigen Right: Soluble OVA 10 ~g in right paw and footpad Left: Soluble BGG 10 ~g in left paw and footpad The earlier observations of Askonas and White (31) , which indicated that antibody production was more pronounced in nodes distant from the site of antigen injection, may have been due to the relatively large amounts of antigen administered (5 rag/site) and thus local tolerance may have been produced (32) .
Attempts to understand the mechanisms of antibody formation can be made at various levels. The present data apply best, perhaps, to the question whether the cell destined to produce a specific antibody in large amounts is a descendant of a cell precommitted to making this antibody, by virtue of having a small amount of the antibody on its surface prior to antigen administration. This restates the clonal selection hypothesis, which presumes proliferation of such committed cells in response to corresponding antigen. In addition, proponents of this view explain the kinetics of antibody formation as well as the changes in affinity of the antibody with time and amount of antigens administered, by the competition for antigen by cells bearing antibodies of different preexisting affinities (33) (34) (35) .
Another view based upon a variety of physiological (36) (37) (38) (39) (40) , morphological (41, 42) , and theoretical considerations (43, 44) would suggest the possibility that a cell destined to make an antibody could have made any antibody. According to this view, the mechanism of antibody formation is more complicated and may entail a series of steps, each being performed by cells of a different lineage and function. The initiation of the immune response being performed by cells derived from the thymus, the final production of an anti° body occurs in cells derived from another cell lineage, the bone marrow (38, 45) . The products of this first interaction (be they an antigen-RNA complex, a viral particle, or episome) then transform uncommitted cells into cells which can produce specific antibodies. Whether this comes about as the result of a selection process at a subcellular level or by entirely different mechanisms must remain a matter for conjecture. Other evidence, recently obtained, suggests that the initiation of the immune response depends on a processing step which appeared to be genetically controlled, and the specificity of which may be different from that of the antibody which is later to be produced in the immune response (46) .
The basic observations of the present paper and those o1 previous authors (12, 13) indicate that, in animals given two different particulate antigens such as sheep and chicken RBC or insoluble particulate OVA and BGG, antibodyforming cells of each separate specificity appear to occur in separate groups. In animals ~mmunized with two different soluble protein antigens, antibodyforming cells of different specificities are randomly intermixed as shown by White (1) and confirmed here. These results suggest that the precursor cell is multipotential and that the microenvironmental site of deposition of the antigen (and therefore the site of the early processing step) determines where antibody-forming cells of each specificity subsequently appear. It is reasonable that the soluble antigens become widely distributed and therefore the sites of processing are also widely distributed; insoluble antigens are more irregularly and less finely deposited. In the context of the present experiment, the injection of these particulate antigens would thus lead to focal and irregularly placed collections of cells capable of efficiently processing the soluble antigen which is given later. It must also be assumed that the products of the antigen-processing interaction must act at only very short distances and/or require actual cell to cell contact, as depicted for example by Thiery (41) and by McFarland et al. (42) .
Also, although most investigators agree that antigen is not detectable in antibody-forming cells, (47, 48) , and that antigen-containing macrophages may have no fixed relationship to any individual antibody-forming cells, the fact remains that large numbers of macrophages (but not the dendritic macrophages of the germinal center) and antibody-forming cells are found in the same general area of lymph nodes and spleen, namely in the areas immediately peripheral to the dense lymphoid nodule and in the medullary cords of lymph nodes and red pulp of the spleen (48) (49) (50) .
The presence of areas of cell intermixing, as well as clusters of cells of single specificity in the lymph nodes of animals immunized with the two insoluble antigens followed by boosting with the two soluble antigens, can be interpreted to mean that some cells capable of processing antigen have become disseminated throughout the lymphoid system late in the immune response. The failure to find cell clusters of single specificity in the spleen of such animals--a site distant from the site of initial immunization--supports this idea.
If antibody production were based on the selection of a small number of precommitted cells followed by rapid proliferation of these cells, animals immunized with two separate antigens should have produced clones or group of cells of a single specificity, both in animals immunized with either soluble or insoluble antigens. Thus the observation made in this as well as in previous studies would favor the idea that which antibody is produced by a cell is determined by the location of that cell in relationship to the site of antigen processing. The production of a single antibody by each individual cell may therefore not be based on a precommitment, but rather preemption of the uncommitted cell by the postulated product of this antigen processing (51) . The data do not clarify how the tremendous diversity of antibody structure is established at the level of the DNA, or whether after the initial interactions the persistence of some antigen is necessary for long continued antibody production.
Another observation which does not fit simple cell selection by antigen theories is that animals immunized with very small amounts of antigen (26) , or insoluble antigens, produce little or no antibody; yet such animals, after a antibody also has a higher affinity than would have been expected to result from the boosting injection alone. The proposed mechanism for this phenomenon is the development of cell populations capable of binding antigen as the result of the initial immunization. If such postulated cell populations are developed, following immunization with small amounts of antigen or insoluble antigens, and are the basis for later cell selection by the boosting antigens, these cells are not detectable by current techniques. The alternative explanation of this phenomenon would be that the priming effect of immunization with very small amounts of antigen or heat-aggregated protein antigens might act by an amplification and increase in efficiency of the antigen-processing mechanism, rather than the production of antibody-forming cells.
Finally, this study has again shown that when animals are immunized with antigenic molecules bearing two separate determinants, the antibodies to these different determinants are made in separate cells. This fact alone suggests that the interaction of antigen with the antibody-forming mechanism is probably more complicated than simple cell selection by antigen.
SUMAq~Ry
The distribution of antibody-forming cells of different specificities in the lymph nodes and spleens of guinea pigs immunized with two separate antigens or with antigens bearing two determinants was studied. When animals were immunized with two soluble protein antigens or antigens in which the two antigenic determinants were on the same molecule, antibody-forming cells of different specificities were always randomly intermixed. However, when animals were immunized with two heat-aggregated particulate protein antigens and then boosted with soluble protein antigens, cells of different specificities were often seen to occur in groups.
These results suggest that antibody-forming cells may not arise by the antigen-stimulated proliferation of precommitted antibody-forming cells, but rather antibody-forming cells arise by a transformation of uncommitted precursor cells as the result of their interactions with a locally produced material derived from the processing of antigen.
I would like to thank Patricia Kaplerchuk for her expert technical assistance. Fro. 2 c. Section from popliteal node of animal 17-3 (Table I) immunized with soluble OVA and BGG in CFA. Cells of each specificity are randomly mixed. High speed Ektachrome. X 104.
Fins. 3 a and 3 b show two different areas from the same section of the left inguinal node from animal number 39-3 (Table V) immunized first with heat-aggregated particulate OVA and BGG followed by boosting with soluble OVA and soluble BGG. (Table V) immunized first with heat-aggregated particulate OVA and BGG followed by boosting with soluble OVA and BGG. Fig. 4 (z shows many green anti-BGG--producing cells and a rare orange anti-OVA-producing cell. It should be noted that the color values seen in the prints do not adequately represent the colors actually seen. This is especially true when high speed Ektaehome is used; here orange cells appear yellow.
